Ask the Experts: A Lifelong Learning Series - The Therapeutic Value of Neuromonitoring

F. Todd Wetzel, MD

Disclosures:

Doan, Adam: Other: Nuvasive Clinical Services  (Salary); Private Investments: Veridical RCM (D).

Vogel, Richard: Board of Directors: American Board Of Neurophysiologic Monitoring (Nonfinancial, Examiner for Board), American Society Of Neurophysiological Monitoring (Nonfinancial, President (2019-2020)); Other: NuVasive Clinical Services (Salary, employment ended May 2021); Stock Ownership: NuVasive (less than 1%).

Wetzel, F. Todd: Other: NASS (C, Paid directly to institution/employer); Stock Ownership: Relievant Medical (40,000 Shares, 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+